Deactivation of implantable cardioverter-defibrillators at end of life.

about

Deactivation of implantable cardioverter-defibrillators at end of life.

Item

http://www.wikidata.org/entity/Q38158220

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Deactivation of implantable cardioverter-defibrillators at end of life.

@en

type

Item

label

Deactivation of implantable cardioverter-defibrillators at end of life.

@en

prefLabel

Deactivation of implantable cardioverter-defibrillators at end of life.

@en

P1476

Deactivation of implantable cardioverter-defibrillators at end of life.

@en

P2093

Colette E Jackson

http://www.w3.org/2001/XMLSchema#string

Roy S Gardner

http://www.w3.org/2001/XMLSchema#string

Stephen J Pettit

http://www.w3.org/2001/XMLSchema#string

P2860

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

Indication to cardioverter-defibrillator therapy and outcome in real world primary prevention. Data from the IRIDE [Italian registry of prophylactic implantation of defibrillators] study.

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Ther

Patient expectations from implantable defibrillators to prevent death in heart failure.

Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial.

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Patient preferences for deactivation of implantable cardioverter-defibrillators.

Brief communication: Management of implantable cardioverter-defibrillators in hospice: A nationwide survey.

The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011.

P304

885-896

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FCA.13.81

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24180544

http://www.w3.org/2001/XMLSchema#string

P921

defibrillator